InvestorsHub Logo
Followers 43
Posts 5405
Boards Moderated 0
Alias Born 03/05/2010

Re: None

Tuesday, 12/01/2015 11:15:31 AM

Tuesday, December 01, 2015 11:15:31 AM

Post# of 92948
Why would China invite OCAT to China? What purpose? Why would Japan not value OCAT's NED technology enough to remunerate share holders decently?

http://www.iddst.com/iddst2015/ScientificProgram9.asp
Title: Moving Pluripotent Stem Cell Therapies to the Clinic: Retinal Cells for the Treatment of Eye Diseases
Dr. Shi-Jiang (John) Lu, Senior Director of Research, Ocata Therapeutics, Inc., USA

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.